Evidence map›Paper›PMID 34276985›Full record

ArticleAnnals of medicine and surgery (2012)2021

Synovial sarcoma of the maxillary sinus - A rare condition managed with a rationalized surgery.

Burhan Hannoun, Ibrahim Hannoun, Albaraa Bara, Areej Alassaf, Eyad M Chatty

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Burhan HannounFaculty of Dentistry, Damascus University, Damascus, Syrian Arab Republic.
Ibrahim HannounFaculty of Dentistry, Damascus University, Damascus, Syrian Arab Republic.
Albaraa BaraFaculty of Dentistry, Damascus University, Damascus, Syrian Arab Republic.
Areej AlassafFaculty of Medicine, Damascus University, Syrian Arab Republic.
Eyad M ChattySyrian College of Pathologists, Department of Pathology, Alassad University Hospital, Damascus, Syria.
Damascus University · SYAl Assad University Hospital · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionand importance: Synovial sarcoma is a type of spindle cell tumors with unknown cellular origin. It can present anywhere throughout the body; however, its onset in the maxillary sinus is an extremely rare condition, making it hard to diagnose. This tumor occurs equally, without predilection for males or females, and the incidence peaks in the age of 35. The diagnosis is confirmed by histopathological study, and the main treatment is complete surgical excision. CASE PRESENTATION: We are reporting a case of a 53-year-old male with a left sided hearing loss accompanied by a left sided nasal block and a vague facial and dental pain. CLINICAL DISCUSSION: Magnetic Resonance Imaging (MRI) showed a heterogeneously enhancing tumor in the maxillary sinus that extended to the pterygopalatine fossa and other surrounding structures, and a biopsy showed the tumor to be a synovial sarcoma. The tumor was managed with a less aggressive curative surgery, and was put on an adjuvant radiotherapy, and is being followed regularly; with no recurrence 5 months after therapy.

conclusionIn conclusion, we are writing this report to introduce a case of synovial sarcoma in a rare location that was managed by a "cosmetically oriented" curative surgery, satisfactory results and prognosis.

Indexed as

Case reportHead and neckMaxillaPterygopalatineSynovial sarcoma

Identifiers

PMID34276985
PMCPMC8267481
OpenAlexW3183107090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.